Skip to main navigation Skip to search Skip to main content

Acute administration of the GLP-1 receptor agonist, Exenatide, restores impaired central responses to food ingestion in type 2 diabetes

  • Paxton Green Health Centre

Research output: Contribution to journal › Meeting abstract

Original languageEnglish
Pages (from-to)S100 - S100
JournalDiabetologia
Volume53
Publication statusPublished - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this